Cheers to the triumphant return of generic drug price deflation

Ben LinkJuly 2, 2021NADAC, Medicaid, Generic, Brand drugs, List prices, Rebates, WAC, IQVIA, Spritam, Hizentra, Sylvant, Ecoza, Gammaked, Forfivo, Tenormin, Akten, Atropine, Multaq, Atripla, Methylphenidate, Paliperidone, Naproxen

Generic drug prices rise for first time in seven months

Ben LinkJune 16, 2021NADAC, Medicaid, Generic, Brand drugs, List prices, Rebates, WAC, IQVIA, Spritam, Hizentra, Sylvant, Ecoza, Gammaked, Forfivo, Tenormin, Akten, Atropine, Multaq, Atripla, Methylphenidate, Paliperidone, Naproxen

The prescription drug supply chain's sky is not falling ... yet

Ever since the COVID-19 pandemic pulled the rug out from under our lives, us nerds in the drug pricing world have been anxiously anticipating what its impact on the prescription drug supply chain will be. This week, CMS released its latest monthly round of prescription drug cost information, which gives us our first bits of insight of how the virus and its stresses on the supply chain are impacting generic drug costs. While it’s too early to tell, the first indicators show that prices are slightly moving northwards, but in general, it doesn’t seem close to being the disaster that many anticipated.

Ben LinkMay 21, 2020NADAC, Medicaid, Generic, COVID, Naproxen, Hydroxychloroquine, Metformin

Drug prices shift as COVID-19 begins making its mark on the supply chain

For the past 20 months, in the pre-COVID-19 era, we’ve released a monthly report called “What’s Happening To Generic Drug Prices,” where we track month-by-month price changes from the CMS National Average Drug Acquisition Cost (NADAC) survey of community pharmacy invoice acquisition costs for prescription drugs. This month, we still are providing that update, but in digging through the latest round of drug pricing data from CMS, we spotted some very interesting drug pricing movement on generic drugs, and one massive increase on a drug that was recently being tested for emergency use for treatment of COVID-19 patients. Check out our latest drug pricing report for important updates on the latest drug price changes, plus an updated NADAC Packed Bubble Chart and Abnormal Drug Price Increase Tracker.

Ben LinkApril 23, 2020NADAC, Medicaid, Generic, COVID, Naproxen, Hydroxychloroquine, Prograf, Tacrolimus, Naprosyn, Mytesi

What’s happening to generic drug prices? March 2020 NADAC Survey Update

It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” We saw more price increases than decreases this past month. Also, for the second month in a row, we saw an increase in annualized spending based on typical utilization trends. It is becoming clear that the generic marketplace is not providing the deflation and efficiency that we have become accustomed to in recent years. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for important updates on the latest generic drug price changes, plus an updated NADAC Packed Bubble Chart.